Table 1.
Patient Specific Parameters
Institution 1 | Institution 2 | |||
---|---|---|---|---|
| ||||
Parameter | BCR+ (N = 35) | BCR− (N = 35) | BCR+ (N = 7) | BCR− (N = 43) |
MRI Receiver coils | ||||
ERC | n = 20 | n = 35 | n = 0 | n = 0 |
PPAC/Surface coil | n = 15 | n = 0 | n = 7 | n = 43 |
Clinical parameters | ||||
Mean age (range) | 62.4 (45–78) y | 58 (46–80) y | 62.6 (53 – 68) y | 62.9 (54 – 72) y |
Mean pretreatment PSA (range) | 20.9 (0.37 – 48.5) ng/mL | 7.1 (0.03 – 21) ng/mL | 12.97 (6–26) ng/mL | 9.37 (3.5–35) ng/mL |
Median Gleason score (range) | 9 (7 – 9) | 7 (6 – 9) | 7 (7 – 9) | 7 (5 – 9) |
Mean follow-up time (range) | 17.2 (0–59) mo | 60 (25–85) mo | 17 (11 – 30) mo | 28.83 (3 – 67) mo |
Median PIRADS (range) | 5 (2 – 5) | 4 (2 – 5) | 5 (4 – 5) | 5 (1 – 5) |
Treatment type | ||||
Radical prostatectomy | n = 22 | n = 34 | n = 7 | n = 43 |
Radiotherapy | n = 10 | n = 0 | n = 0 | n = 0 |
LHRH | n = 3 | n = 1 | n = 0 | n = 0 |
Note: ERC = Endo-rectal coil, PPAC = Pelvic-phased array coil, PSA = prostate-specific antigen, LHRH = luteinizing hormone-releasing hormone therapy